Sökning: onr:"swepub:oai:lup.lub.lu.se:0a13ded5-c075-48dd-8857-816e5753e913" >
Outcomes and perfor...
Outcomes and performance of the ACURATE neo2 transcatheter heart valve in clinical practice : one-yearresults of the ACURATE neo2 PMCF Study
-
- Kim, Won Keun (författare)
- Kerckhoff Klinik
-
- Möllmann, Helge (författare)
- St.-Johannes-Hospital Dortmund
-
- Montorfano, Matteo (författare)
- Vita-Salute San Raffaele University
-
visa fler...
-
- Ellert-Gregersen, Julia (författare)
- Odense University Hospital
-
Rudolph, Tanja K. (författare)
-
- Van Mieghem, Nicolas M. (författare)
- Erasmus University Medical Center
-
- Hilker, Michael (författare)
- University Hospital Regensburg
-
- Amat-Santos, Ignacio (författare)
- University of Valladolid
-
- Terkelsen, Christian Juhl (författare)
- Aarhus University Hospital
-
- Petronio, Anna Sonia (författare)
- University Hospital of Pisa
-
- Stella, Pieter (författare)
- University Medical Center Utrecht
-
- Götberg, Matthias (författare)
- Lund University,Lunds universitet,Kardiologi,Sektion II,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Cardiology,Section II,Department of Clinical Sciences, Lund,Faculty of Medicine,Skåne University Hospital
-
- Rück, Andreas (författare)
- Karolinska Institutet
-
- Kasel, A. Markus (författare)
- University Hospital of Zurich
-
- Trillo, Ramiro (författare)
- Complejo Hospitalario Universitario de Santiago
-
- Appleby, Clare (författare)
- Liverpool Heart and Chest Hospital
-
- Barbanti, Marco (författare)
- Kore University of Enna
-
- Blanke, Philipp (författare)
- St. Paul’s Hospital
-
Asch, Federico M. (författare)
-
- Modolo, Rodrigo (författare)
- Boston Scientific Corporation
-
- Allocco, Dominic J. (författare)
- Boston Scientific Corporation
-
- Tamburino, Corrado (författare)
- Azienda Ospedaliero Universitaria-Policlinico Duilio Casula
-
visa färre...
-
Kerckhoff Klinik St-Johannes-Hospital Dortmund (creator_code:org_t)
- 2024
- 2024
- Engelska 10 s.
-
Ingår i: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. - 1969-6213. ; 20:1, s. 85-94
- Relaterad länk:
-
http://dx.doi.org/10...
-
visa fler...
-
https://lup.lub.lu.s...
-
https://doi.org/10.4...
-
http://kipublication...
-
http://kipublication...
-
visa färre...
Abstract
Ämnesord
Stäng
- BACKGROUND: Transcatheter aortic valve implantation is an effective treatment for patients with aortic stenosis; however, complications related to paravalvular leakage (PVL) persist, including increased risk of mortality, cardiovascular mortality, and rehospitalisation. AIMS: We sought to evaluate the clinical outcomes and valve performance at 1 year in patients with severe aortic stenosis treated with the ACURATE neo2 valve in a post-market clinical setting. METHODS: Valve Academic Research Consortium-2 safety events were assessed up to 1 year. Independent core laboratories evaluated echocardiographic measures of valve performance and hypoattenuated leaflet thickening (HALT; as measured by four-dimensional computed tomography). RESULTS: The study enrolled 250 patients (64% female; mean age: 81 years; baseline Society of Thoracic Surgeons risk score: 2.9±2.0%); 246 patients were implanted with ACURATE neo2. All-cause mortality was 0.8% at 30 days and 5.1% at 1 year. The 1-year rates for stroke and disabling stroke were 3.0% and 1.3%, respectively. Overall, HALT of >50% leaflet involvement of at least one leaflet was present in 9% of patients at 30 days and in 12% of patients at 1 year. No association was observed between the presence of HALT and 1-year clinical or haemodynamic outcomes. Early haemodynamic improvements were maintained up to 1 year (mean aortic valve gradient: 47.6±14.5 mmHg at baseline, 7.6±3.2 mmHg at 1 year; mean aortic valve area: 0.7±0.2 cm2 at baseline, 1.7±0.4 cm2 at 1 year). At 1 year, 99% of patients had mild or no/trace PVL (<1% had moderate PVL; no patient had severe PVL). CONCLUSIONS: The study outcomes confirm favourable performance and safety up to 1 year in patients treated with ACURATE neo2 in routine clinical practice. (ClinicalTrials.gov: NCT04655248).
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Kardiologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)
Publikations- och innehållstyp
- art (ämneskategori)
- ref (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Kim, Won Keun
-
Möllmann, Helge
-
Montorfano, Matt ...
-
Ellert-Gregersen ...
-
Rudolph, Tanja K ...
-
Van Mieghem, Nic ...
-
visa fler...
-
Hilker, Michael
-
Amat-Santos, Ign ...
-
Terkelsen, Chris ...
-
Petronio, Anna S ...
-
Stella, Pieter
-
Götberg, Matthia ...
-
Rück, Andreas
-
Kasel, A. Markus
-
Trillo, Ramiro
-
Appleby, Clare
-
Barbanti, Marco
-
Blanke, Philipp
-
Asch, Federico M ...
-
Modolo, Rodrigo
-
Allocco, Dominic ...
-
Tamburino, Corra ...
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Kardiologi
- Artiklar i publikationen
-
EuroIntervention ...
- Av lärosätet
-
Lunds universitet
-
Karolinska Institutet